Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT (Q80796096)

From Wikidata
Revision as of 10:35, 5 November 2021 by Jsamwrites (talk | contribs) (‎Updated Item: Added main subject (P921): ovarian cancer (Q172341) with Wikidata:Tools/ItemSubjector (details))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
scientific article published on 13 August 2007
edit
Language Label Description Also known as
English
Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT
scientific article published on 13 August 2007

    Statements

    title
    Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    17698804
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698804%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    3 January 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q80796096&oldid=1522532767"